Central Sensitization in Post-Knee Replacement Pain and Relation to OA Pathology

膝关节置换术后疼痛的中枢敏化及其与 OA 病理学的关系

• 批准号: 8437321
• 负责人: TUHINA NEOGI
• 金额: $ 64.62万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-14 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8437321
• 关键词: Address; Area; Arthritis; Chronic; Cohort Studies; Data; Degenerative polyarthritis; Disease; Disorder by Site; Elderly; Evaluation; Fibromyalgia; Funding; Goals; Grant; Impairment; Individual; Inflammation; Inflammation Mediators; Inflammatory; Joints; Knee; Knee Osteoarthritis; Knowledge; Lead; Leptin; Lower Extremity; Measures; Mechanics; Nervous system structure; Neuraxis; Neurons; Neuropathy; Obesity; Operative Surgical Procedures; Outcome; Pain; Pain Threshold; Pain management; Pathology; Patients; Peripheral; Persons; Plasma; Play; Positioning Attribute; Process; Proxy; Psychological Factors; Public Health; Relative (related person); Research; Resolution; Risk; Risk Factors; Role; Severities; Source; Synovitis; TNF gene; Testing; Therapeutic Intervention; Tissues; United States; United States National Institutes of Health; Work; adiponectin; base; central sensitization; clinically relevant; cohort; disability; effusion; functional outcomes; high risk; improved; innovation; insight; knee replacement arthroplasty; novel; painful neuropathy; pressure; somatosensory

DESCRIPTION (provided by applicant): Knee osteoarthritis (OA) is the leading cause of lower extremity disability among older adults in the United States. Knee replacement (KR) is the only definitive treatment available for knee OA presently. Reflecting this, ~0.5 million KRs were performed in 2004, with ~3.5 million projected by the year 2030. Despite replacement of the diseased joint, 20-30% of patients have inadequate pain relief from this presumably definitive major surgical procedure aimed at improving pain. The reason for suboptimal pain relief is not entirely clear. Central sensitization, which is an abnormal excitability of neurons in the central nervous system, causes heightened pain sensitivity and is therefore a plausible contributing factor to ongoing pain after KR. Central sensitization can occur for a variety of reasons, including inflammatory inputs from diseased tissue and other systemic sources (such as obesity, a major risk factor for OA, which is associated with low-grade inflammation), and the surgery itself. Preliminary pilot data support the cross-sectional relation of central sensitizatio to severe pain post-KR and radiographic knee OA, suggesting the possibility of OA pathology contributing to sensitization. The objective of this study is to comprehensively study the relation of: 1) central sensitization to pain post-KR; 2) the duration and severity inflammatory features of OA (synovitis, effusion) as well as inflammatory mediators that may act locally or systemically (TNF-¿, adiponectin, leptin) to central sensitization. These studies will provide insight into potential pathophysiologic mechanisms underlying post-KR and knee OA pain, and occurrence of central sensitization. The study will be conducted within the NIH-funded Multicenter Osteoarthritis (MOST) Study, which is a cohort of ~3000 older adults with knee OA of varying severity and duration as well as persons who are at high risk for knee OA, who have had longitudinal standardized assessments of disease, pain, and function over 7 years to date. This study will create a new post-KR cohort to enable greater assessments of central sensitization pre- and post-KR as these measures were not obtained in all those with KR previously, and will enable assessment of neuropathic pain as a contributor to post-KR pain. Two measures of central sensitization will be evaluated: 1) temporal summation and 2) pressure pain threshold, which is a marker of peripheral and/or central sensitization at sites of disease, or of central sensitization when assessed at an otherwise normal area. These evaluations will occur in the context of other pertinent factors associated with poor KR pain outcomes that are comprehensively collected in this cohort. Insight into the role of central sensitization in pain post-KR, and the inflammatory pathology of OA or other systemic inflammatory mediators that may contribute to central sensitization will offer opportunities to develop rational new targets fo improving pain outcomes in knee OA earlier in the disease process, as well as improving pain outcomes post-KR, which is currently the only definitive therapy available for knee OA. PUBLIC HEALTH RELEVANCE: Knee replacement surgery is the only definitive treatment available for osteoarthritis, the leading cause of lower extremity pain and disability among older adults in the United States, yet a substantial number of people continue to have pain after knee replacement. Accordingly, there is a vital need to understand what factors may explain why some people do not achieve adequate pain relief post-knee replacement, particularly since such a large number of such surgeries are performed in the United States. This research will provide important information regarding nervous system alterations (sensitization) as a potential risk factor for pain persistence post-knee replacement, and whether inflammation may contribute to these alterations, thereby increasing our understanding of potential causes of and treatment targets for pain in osteoarthritis and post-knee replacement.

描述（由申请人提供）：膝关节骨关节炎（OA）是美国老年人下肢残疾的主要原因。膝关节置换术（KR）是目前唯一确定的治疗膝关节OA的方法。有鉴于此，2004年进行了约50万例KRs，预计到2030年将进行约350万例KRs。尽管对患病关节进行了置换，但20-30%的患者在这种可能旨在改善疼痛的主要外科手术中疼痛缓解不足。止痛效果欠佳的原因尚不完全清楚。中枢致敏是中枢神经系统中神经元的异常兴奋性，会导致疼痛敏感性升高，因此可能是KR后持续疼痛的一个因素。中枢致敏的发生有多种原因，包括病变组织和其他系统性来源的炎症输入（如肥胖，OA的主要危险因素，与低度炎症相关），以及手术本身。初步试验数据支持膝关节骨性关节炎对kr后剧烈疼痛的中枢致敏与影像学上的膝关节骨性关节炎之间的横断面关系，表明骨性关节炎病理可能导致致敏。本研究的目的是全面研究二者之间的关系